Precision BioSciences (NASDAQ: DTIL) has announced that it will be unveiling its third quarter financial results on Monday 4th November 2024. This eagerly anticipated announcement is scheduled to occur before market open, ensuring that investors and analysts have the opportunity to gain valuable insights into the company's performance during the quarter.
the concern is expected to report an estimated per share $1.92 loss for the quarter, as predicted by financial analysts on Wall Street. Furthermore, the company is anticipated to disclose a total revenue of $6.36 million during this period.
In the previous year's corresponding quarter, the company's earnings report revealed a per-share loss of $2.1. Moreover, the company achieved a remarkable total revenue of $13.12 million during that quarter.
Wall Street analysts have provided their insights on the company's performance for the year, forecasting a total revenue of $80.43 million. Additionally, they anticipate the earnings per share to reach loss of $0.36 during the fiscal year.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q1 2024 | $-0.35 | -52.2% | 17.58 M | +100.3% |
| Q4 2023 | $-3.35 | -1,188.5% | 7.04 M | -33.6% |
| Q3 2023 | $-2.10 | -854.5% | 13.12 M | +78.2% |
| Q2 2023 | $-0.10 | +78.3% | 19.79 M | +418.0% |
| *Growth on year-over-year basis | ||||
Precision BioSciences (DTIL) closed Friday's regular trading session at $9.02, indicating a 5.37 percent gain. The stock fluctuated between $8.67 and $9.12 during the day, with a volume of 76.90 thousand shares.
